Fennec Pharmaceuticals Inc.
FENC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $261,041 | $229,611 | $167,950 | $173,547 |
| - Cash | $21,947 | $18,705 | $22,676 | $26,634 |
| + Debt | $0 | $19,364 | $18,081 | $19,340 |
| Enterprise Value | $239,094 | $230,270 | $163,355 | $166,253 |
| Revenue | $12,462 | $9,652 | $8,751 | $7,925 |
| % Growth | 29.1% | 10.3% | 10.4% | – |
| Gross Profit | $11,802 | $8,685 | $8,378 | $7,256 |
| % Margin | 94.7% | 90% | 95.7% | 91.6% |
| EBITDA | -$1 | -$2,533 | -$782 | -$909 |
| % Margin | -0% | -26.2% | -8.9% | -11.5% |
| Net Income | -$638 | -$3,152 | -$1,165 | -$1,985 |
| % Margin | -5.1% | -32.7% | -13.3% | -25% |
| EPS Diluted | -0.02 | -0.12 | -0.042 | -0.057 |
| % Growth | 83.3% | -184.4% | 26.4% | – |
| Operating Cash Flow | $1,493 | -$3,686 | -$4,318 | -$1,474 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $1,493 | -$3,686 | -$4,318 | -$1,474 |